Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis

Fig. 3

Serum phosphate concentrations during baseline and sucroferric oxyhydroxide follow-up (Q1−Q4). a Mean ± SD serum phosphate concentrations. b Proportion of patients achieving target serum phosphate of ≤1.78 mmol/L and ≤ 1.45 mmol/L. ***p < 0.0001 (vs baseline). Mean values are shown in the table. Abbreviations: PB, phosphate binder; SD, standard deviation; SFOH, sucroferric oxyhydroxide

Back to article page